Preview

PDF (Author version) 130327 - Subcut...pdf | Download (328kB) | Preview

Abstract

Background:Topical application, oral, and IV injection of tranexamic acid (TXA) have been used to reduce surgical bleeding.Objective:To evaluate the safety and efficacy of TXA injected subcutaneously to reduce bleeding during dermatologic surgery.Methods:In this double-blinded, placebo-controlled, randomized prospective study, 131 patients were randomized to subcutaneous injection of lidocaine 2% diluted 1:1 with either saline (placebo) or TXA 100 mg/1 mL before surgery. Before the second stage or closure, size measurements of bloodstain impregnation on Telfa and surgical wound size were recorded and analyzed using mixed-effects linear regression. Subjective evaluation of hemostasis was performed using 4-point scale grading and analyzed using Fischer's exact test.Results:One hundred twenty-seven patients completed the study. The bloodstain to surgical wound size ratio was smaller in the TXA group (1.77) compared with the placebo group (2.49) (p Conclusion:Subcutaneous injection of TXA was safe, reduced bleeding during dermatologic surgery, and particularly effective for patients receiving anticoagulation treatment.

Item Type:	Article
Authors/Creators:	Zilinsky, I and Barazani, TB and Visentin, D and Ahuja, K and Martinowitz, U and Haik, J
Keywords:	Tranexamic acid; hemostasis; anticoagulants; Mohs micrographic surgery
Journal or Publication Title:	Dermatologic Surgery
Publisher:	Blackwell Publishing Inc
ISSN:	1076-0512
DOI / ID Number:	https://doi.org/10.1097/DSS.0000000000001786
Copyright Information:	© 2019 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved. This is a non-final version of an article published in final form as the article cited above.
Related URLs:	Google Scholar: Visentin, D UTAS Profile: Visentin, D Google Scholar: Ahuja, K UTAS Profile: Ahuja, K
Item Statistics:	View statistics for this item

Actions (login required)

Item Control Page